PlainRecalls
FDA Drug Low Class III Terminated

Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.

Reported: June 3, 2020 Initiated: May 26, 2020 #D-1281-2020

Product Description

Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.

Reason for Recall

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Details

Units Affected
1,313,333 tablets
Distribution
TN
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 1,313,333 tablets.
Why was this product recalled?
Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 3, 2020. Severity: Low. Recall number: D-1281-2020.